AS MEDICINE becomes more specialised, global, and time-sensitive, life sciences companies need logistics networks built for precision, visibility, and reliability.

FedEx Life Sciences brings together the strength of the FedEx global network with a dedicated healthcare team and advanced monitoring capabilities to serve pharmaceutical and healthcare professionals working to deliver care to patients around the world.

As part of the launch, Nick Gennari has been appointed president of healthcare and life sciences. Gennari and his team’s efforts have been instrumental in growing FedEx healthcare revenue to approximately $10 billion globally. 

 FedEx Life Sciences builds on significant investments the company has made in healthcare infrastructure and technology. In 2025, FedEx secured IATA CEIV Pharma Corporate Certification, achieving corporate-level certification for ground handling across its air hubs and ramps. In addition, FedEx recently appointed a vice president of global quality, healthcare, and life sciences to oversee global quality management systems for the organization and support the standards required by pharmaceutical and medical device manufacturers.

FedEx has also expanded its life sciences footprint with a total of six Life Sciences Centers globally. Additionally, a direct flight between Indianapolis and Dublin has strengthened transatlantic connectivity between these two critical pharmaceutical manufacturing hubs, as the company continues to connect global pharmaceutical epicenters. 

These assets are supported by FedEx Surround, a monitoring and intervention service that uses machine learning to provide proactive, end-to-end visibility for critical shipments, identify potential disruptions, and support intervention when timing, temperature, and reliability are essential.